References
- Sharma HS, Sharma A. New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents. Expert Rev. Neurother. 11(8), 1121–1124 (2011).
- Sharma HS, Sharma A. New therapeutic advances in CNS injury and repair. Expert Rev. Neurother. 12(8), 901–905 (2012).
- Buda O, Arsene D, Ceausu M, Dermengiu D, Curca GC. Georges Marinesco and the early research in neuropathology. Neurology 72(1), 88–91 (2009).
- Chudley AE. Genetic landmarks through philately: Georges Marinesco (1863–1938). Clin. Genet. 64(4), 297–299 (2003).
- Sharma HS, Sharma A, Mössler H, Muresanu DF. Neuroprotective effects of cerebrolysin, a combination of different active fragments of neurotrophic factors and peptides on the whole body hyperthermia-induced neurotoxicity: modulatory roles of co-morbidity factors and nanoparticle intoxication. Int. Rev. Neurobiol. 102, 249–276 (2012).
- Sharma HS, Castellani RJ, Smith MA, Sharma A. The blood–brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery. Int. Rev. Neurobiol. 102, 47–90 (2012).
- Menon PK, Muresanu DF, Sharma A, Mössler H, Sharma HS. Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals. CNS Neurol. Disord. Drug Targets 11(1), 40–49 (2012).
- Sharma HS, Sharma A. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4(2), 184–203 (2012).
- Sharma HS, Patnaik R, Sharma A. Diabetes aggravates nanoparticles induced breakdown of the blood–brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol. 10(12), 7931–7945 (2010).